Use of CEA and CA15-3 to Predict Axillary Lymph Node Metastasis in Patients with Breast Cancer
Open Access
- 1 January 2016
- journal article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 7 (1) , 37-41
Abstract
Purpose: The clinical significance of preoperative serum levels of carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) in breast cancer is controversial. The purpose of this study was to assess the clinical value of preoperative serum levels of CEA and CA 15-3 on the risk of axillary lymph node metastasis (ALNM) in patients with breast cancer.Keywords
This publication has 25 references indexed in Scilit:
- Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancerThe Breast, 2014
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology, 2013
- Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancerAnnals of Oncology, 2012
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2011
- Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node MetastasesAnnals of Surgery, 2010
- Prospective Evaluation of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 15.3 (CA 15.3) in Patients with Primary Locoregional Breast CancerClinical Chemistry, 2010
- Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomesAnnals of Oncology, 2007
- Chronic Arm Morbidity After Curative Breast Cancer Treatment: Prevalence and Impact on Quality of LifeJournal of Clinical Oncology, 2002
- Arm Edema in Breast Cancer PatientsJNCI: Journal of the National Cancer Institute, 2001
- Long-Term Morbidity Following Axillary Dissection in Breast Cancer Patients – Clinical Assessment, Significance for Life Quality and the Impact of Demographic, Oncologic and Therapeutic FactorsBreast Cancer Research and Treatment, 2000